The development of the ProMAS: a Probabilistic Medication Adherence Scale

M. Kleppe, J.P.W. Lacroix, J.R.C. Ham, C.J.H. Midden

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)
87 Downloads (Pure)

Abstract

Current self-report medication adherence measures often provide heavily skewed results with limited variance, suggesting that most participants are highly adherent. This contrasts with findings from objective adherence measures. We argue that one of the main limitations of these self-report measures is the limited range covered by the behaviors assessed. That is, the items do not match the adherence behaviors that people perform, resulting in a ceiling effect. In this paper, we present a new self-reported medication adherence scale based on the Rasch model approach (the ProMAS), which covers a wide range of adherence behaviors. The ProMAS was tested with 370 elderly receiving medication for chronic conditions. The results indicated that the ProMAS provided adherence scores with sufficient fit to the Rasch model. Furthermore, the ProMAS covered a wider range of adherence behaviors compared to the widely used Medication Adherence Report Scale (MARS) instrument, resulting in more variance and less skewness in adherence scores. We conclude that the ProMAS is more capable of discriminating between people with different adherence rates than the MARS.
Original languageEnglish
Pages (from-to)355-367
JournalPatient Preference and Adherence
Volume9
DOIs
Publication statusPublished - 2015

Keywords

  • questionnaire design
  • probabilistic models
  • methodology

Cite this

@article{0c51dd1f0ad7433c91cf8109fef94de0,
title = "The development of the ProMAS: a Probabilistic Medication Adherence Scale",
abstract = "Current self-report medication adherence measures often provide heavily skewed results with limited variance, suggesting that most participants are highly adherent. This contrasts with findings from objective adherence measures. We argue that one of the main limitations of these self-report measures is the limited range covered by the behaviors assessed. That is, the items do not match the adherence behaviors that people perform, resulting in a ceiling effect. In this paper, we present a new self-reported medication adherence scale based on the Rasch model approach (the ProMAS), which covers a wide range of adherence behaviors. The ProMAS was tested with 370 elderly receiving medication for chronic conditions. The results indicated that the ProMAS provided adherence scores with sufficient fit to the Rasch model. Furthermore, the ProMAS covered a wider range of adherence behaviors compared to the widely used Medication Adherence Report Scale (MARS) instrument, resulting in more variance and less skewness in adherence scores. We conclude that the ProMAS is more capable of discriminating between people with different adherence rates than the MARS.",
keywords = "questionnaire design, probabilistic models, methodology",
author = "M. Kleppe and J.P.W. Lacroix and J.R.C. Ham and C.J.H. Midden",
year = "2015",
doi = "10.2147/PPA.S76749",
language = "English",
volume = "9",
pages = "355--367",
journal = "Patient Preference and Adherence",
issn = "1177-889X",
publisher = "Dove Medical Press Ltd.",

}

The development of the ProMAS : a Probabilistic Medication Adherence Scale. / Kleppe, M.; Lacroix, J.P.W.; Ham, J.R.C.; Midden, C.J.H.

In: Patient Preference and Adherence, Vol. 9, 2015, p. 355-367.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - The development of the ProMAS

T2 - a Probabilistic Medication Adherence Scale

AU - Kleppe, M.

AU - Lacroix, J.P.W.

AU - Ham, J.R.C.

AU - Midden, C.J.H.

PY - 2015

Y1 - 2015

N2 - Current self-report medication adherence measures often provide heavily skewed results with limited variance, suggesting that most participants are highly adherent. This contrasts with findings from objective adherence measures. We argue that one of the main limitations of these self-report measures is the limited range covered by the behaviors assessed. That is, the items do not match the adherence behaviors that people perform, resulting in a ceiling effect. In this paper, we present a new self-reported medication adherence scale based on the Rasch model approach (the ProMAS), which covers a wide range of adherence behaviors. The ProMAS was tested with 370 elderly receiving medication for chronic conditions. The results indicated that the ProMAS provided adherence scores with sufficient fit to the Rasch model. Furthermore, the ProMAS covered a wider range of adherence behaviors compared to the widely used Medication Adherence Report Scale (MARS) instrument, resulting in more variance and less skewness in adherence scores. We conclude that the ProMAS is more capable of discriminating between people with different adherence rates than the MARS.

AB - Current self-report medication adherence measures often provide heavily skewed results with limited variance, suggesting that most participants are highly adherent. This contrasts with findings from objective adherence measures. We argue that one of the main limitations of these self-report measures is the limited range covered by the behaviors assessed. That is, the items do not match the adherence behaviors that people perform, resulting in a ceiling effect. In this paper, we present a new self-reported medication adherence scale based on the Rasch model approach (the ProMAS), which covers a wide range of adherence behaviors. The ProMAS was tested with 370 elderly receiving medication for chronic conditions. The results indicated that the ProMAS provided adherence scores with sufficient fit to the Rasch model. Furthermore, the ProMAS covered a wider range of adherence behaviors compared to the widely used Medication Adherence Report Scale (MARS) instrument, resulting in more variance and less skewness in adherence scores. We conclude that the ProMAS is more capable of discriminating between people with different adherence rates than the MARS.

KW - questionnaire design

KW - probabilistic models

KW - methodology

U2 - 10.2147/PPA.S76749

DO - 10.2147/PPA.S76749

M3 - Article

C2 - 25784791

VL - 9

SP - 355

EP - 367

JO - Patient Preference and Adherence

JF - Patient Preference and Adherence

SN - 1177-889X

ER -